Magellan Update October 2023

GMP LAB CONSTRUCTION COMPLETED Magellan has completed the construction of the GMP laboratory facility, with the emphasis now on balancing and testing systems. The installation of the Environmental Monitoring System (EMS) is largely complete. The research and development lab is being used to evaluate Bioreactor manufacturing methods and donor cells culturing, with a range of tests […]

Magellan are pleased to announce the results of our Phase 1/2 allogenic trial. The research findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI), which publishes the evidence-based, international consensus guidelines on osteoarthritis management.  

Australian Health Minister announced a $7 million grant to Magellan Stem Cells – read more here

Should you want further information regarding our results or media release please email info@magellanstemcells.com.au or call 03 9270 8080.

Investment Enquiry

Download the full Investor Presentation